PRECIPIO, INC. Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed
PRECIPIO, INC. (PRPO) reported Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed of $2.68 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed · last filed 2019-04-16
- PRECIPIO, INC. business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2017-12-31 was $0.00.
- PRECIPIO, INC. business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2017-09-30 was $73.00K.
- PRECIPIO, INC. business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2017-06-30 was $2.60M.
- PRECIPIO, INC. business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2016-09-30 was $0.00.
- PRECIPIO, INC. business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2017 was $2.68M.
| Period end | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 3 month | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 6 month | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 9 month | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | $73.00K derived: sum of 2 quarters · filed 2019-04-16 | $2.68M derived: sum of 3 quarters · filed 2019-04-16 | $2.68M 10-K · filed 2019-04-16 |
| 2017-09-30 | $73.00K 10-Q · filed 2018-11-19 | $2.68M derived: sum of 2 quarters · filed 2018-11-19 | $2.68M 10-Q · filed 2018-11-19 | |
| 2017-06-30 | $2.60M 10-Q · filed 2018-08-16 | $2.60M 10-Q · filed 2018-08-16 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-20 | $0.00 derived: sum of 2 quarters · filed 2017-11-20 | $0.00 10-Q · filed 2017-11-20 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-22 | $0.00 10-Q · filed 2017-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |